Form: EFFECT

Notice of Effectiveness

April 27, 2023

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: April 27, 2023
Accession Number: 0001628280-23-012931
Submission Type: POS AM
CIK: 0001534120
Company Name: Avalo Therapeutics, Inc.
File Number: 333-254000